The total amount of venture capital investing in genomics firms rose to $392 million in 2012, up from $332 million in 2011, according to the blog Seqonomics.

The amount is the most in VC funding to genomics firms that Seqonomics has found, going back to 2006. However, rather than there being more VC deals in 2012, Sanger Institute postdoctoral fellow Art Wuster says that the higher amount in total investments results from a higher average for each investment.